Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The goal of Phase I of this clinical research study is to find the highest tolerable dose of RAD001 (everolimus) when given in combination with the standard chemotherapy regimens to patients with ALL. The goal of Phase II of this study is to learn if the drug combinations can help to control ALL. The safety of these drug combinations will be also studied in both phases.
Critère d'inclusion
- leukemia,Acute Lymphocytic Leukemia